Co-Authors
This is a "connection" page, showing publications co-authored by MARIA SUAREZ-ALMAZOR and MARIA DE LOS ANGELES LOPEZ-OLIVO.
Connection Strength
21.550
-
A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease. Eur J Cancer. 2024 Aug; 207:114148.
Score: 0.957
-
Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors. Cancers (Basel). 2023 Aug 07; 15(15).
Score: 0.905
-
Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study. Cancers (Basel). 2023 May 10; 15(10).
Score: 0.890
-
Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritis. Clin Rheumatol. 2023 Aug; 42(8):2053-2068.
Score: 0.887
-
A systematic review and meta-analysis of e-cigarette use among cancer survivors. J Cancer Surviv. 2024 Jun; 18(3):1059-1074.
Score: 0.881
-
A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis. PLoS One. 2022; 17(12):e0279065.
Score: 0.865
-
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis. Semin Arthritis Rheum. 2022 10; 56:152072.
Score: 0.841
-
Preferred Strategies for Delivering Health Information to Patients With Musculoskeletal Disorders: A Qualitative Study. J Clin Rheumatol. 2022 Jan 01; 28(1):e102-e109.
Score: 0.810
-
Randomized Controlled Trial of Patient Education Tools for Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 10; 73(10):1470-1478.
Score: 0.791
-
A Randomized Controlled Trial Comparing Two Self-Administered Educational Strategies for Patients With Knee Osteoarthritis. ACR Open Rheumatol. 2021 Mar; 3(3):185-195.
Score: 0.762
-
Quality appraisal of educational websites about osteoporosis and bone health. Arch Osteoporos. 2021 02 10; 16(1):28.
Score: 0.761
-
Psychosocial Determinants of Total Knee Arthroplasty Outcomes Two Years After Surgery. ACR Open Rheumatol. 2020 Oct; 2(10):573-581.
Score: 0.742
-
Digital Patient Education and Decision Aids. Rheum Dis Clin North Am. 2019 05; 45(2):245-256.
Score: 0.666
-
Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis. J Rheumatol. 2019 09; 46(9):1164-1167.
Score: 0.665
-
Treating Early Undifferentiated Arthritis: A Systematic Review and Meta-Analysis of Direct and Indirect Trial Evidence. Arthritis Care Res (Hoboken). 2018 09; 70(9):1355-1365.
Score: 0.636
-
Development and Pilot Testing of Multimedia Patient Education Tools for Patients With Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 02; 70(2):213-220.
Score: 0.613
-
Rituximab for rheumatoid arthritis. Cochrane Database Syst Rev. 2015 Jan 20; 1:CD007356.
Score: 0.500
-
Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2014 Jun 10; (6):CD000957.
Score: 0.480
-
Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer. 2012 Nov; 20(11):2985-98.
Score: 0.425
-
Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012 Sep 05; 308(9):898-908.
Score: 0.424
-
Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol. 2012 Mar; 18(2):61-6.
Score: 0.410
-
Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis. 2011 Oct; 70(10):1775-81.
Score: 0.393
-
The updated guidelines on the use of rituximab in rheumatoid arthritis. Rheumatology (Oxford). 2011 Dec; 50(12):2153-4.
Score: 0.387
-
Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum. 2008 Nov 15; 59(11):1625-38.
Score: 0.326
-
Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers: Usability and Acceptability Study. JMIR Cancer. 2024 10 25; 10:e53443.
Score: 0.246
-
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set. Semin Arthritis Rheum. 2024 Feb; 64:152343.
Score: 0.232
-
COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review. J Immunother Precis Oncol. 2023 May; 6(2):103-110.
Score: 0.219
-
COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis. J Immunother Cancer. 2023 02; 11(2).
Score: 0.218
-
Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan. PLoS One. 2022; 17(10):e0275676.
Score: 0.214
-
Stem cell transplantation for systemic sclerosis. Cochrane Database Syst Rev. 2022 07 29; 7:CD011819.
Score: 0.211
-
Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis. Vaccines (Basel). 2022 Jul 27; 10(8).
Score: 0.211
-
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group. Semin Arthritis Rheum. 2023 02; 58:152028.
Score: 0.208
-
Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer. JAMA Netw Open. 2022 04 01; 5(4):e225432.
Score: 0.206
-
Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients With Rheumatoid Arthritis Worldwide: An Outcome Measures in Rheumatology Systematic Review. Arthritis Care Res (Hoboken). 2021 05; 73(5):649-657.
Score: 0.193
-
Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis. J Manag Care Spec Pharm. 2021 01; 27(1):73-83.
Score: 0.189
-
Reply. Arthritis Care Res (Hoboken). 2020 12; 72(12):1828-1829.
Score: 0.188
-
Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv. 2020 04 28; 4(8):1746-1755.
Score: 0.180
-
Systematic Review of Recommendations on the Use of Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Cancer. Arthritis Care Res (Hoboken). 2020 03; 72(3):309-318.
Score: 0.178
-
Interactions and perceptions of patients with rheumatoid arthritis participating in an online support group. Clin Rheumatol. 2020 Jun; 39(6):1775-1782.
Score: 0.177
-
Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies. PLoS One. 2020; 15(1):e0227765.
Score: 0.177
-
A comprehensive scoping review to identify standards for the development of health information resources on the internet. PLoS One. 2019; 14(6):e0218342.
Score: 0.170
-
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease. Ann Intern Med. 2018 07 17; 169(2):133-134.
Score: 0.159
-
Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study. Clin Rheumatol. 2018 Jul; 37(7):1791-1797.
Score: 0.155
-
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic Review. Ann Intern Med. 2018 01 16; 168(2):121-130.
Score: 0.153
-
Online Educational Tool to Promote Bone Health in Cancer Survivors. J Health Commun. 2017 10; 22(10):808-817.
Score: 0.150
-
Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report. J Rheumatol. 2017 Dec; 44(12):1894-1898.
Score: 0.148
-
Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open. 2017 03 01; 7(3):e013242.
Score: 0.145
-
Effect of Body Mass Index and Psychosocial Traits on Total Knee Replacement Costs in Patients with Osteoarthritis. J Rheumatol. 2016 08; 43(8):1600-6.
Score: 0.138
-
Assessing information needs on bone health in cancer survivors. J Cancer Surviv. 2016 06; 10(3):480-8.
Score: 0.132
-
Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res (Hoboken). 2014 Apr; 66(4):592-9.
Score: 0.118
-
Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes. J Rheumatol. 2013 Aug; 40(8):1337-43.
Score: 0.112
-
Febuxostat for treating chronic gout. Cochrane Database Syst Rev. 2012 Nov 14; 11:CD008653.
Score: 0.108
-
Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis. Cancer Treat Rev. 2013 Feb; 39(1):97-104.
Score: 0.106
-
A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol. 2010 Sep; 29(9):947-55.
Score: 0.090
-
Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol. 2009 Feb; 62(2):128-37.
Score: 0.081
-
Factors Associated With Adherence of Cervical Cancer Screening in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2024 09; 76(9):1224-1231.
Score: 0.060
-
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunology. 2023; 12(1):2261264.
Score: 0.057
-
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group. Semin Arthritis Rheum. 2023 02; 58:152110.
Score: 0.054
-
Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative. Semin Arthritis Rheum. 2021 10; 51(5):1113-1116.
Score: 0.049
-
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 03 10; 3:CD012591.
Score: 0.036
-
Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J. 2010; 128(5):309-10.
Score: 0.022
-
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ. 2009 Nov 24; 181(11):787-96.
Score: 0.022
-
Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD007848.
Score: 0.022